- Home
- RDY vs IMVT Comparison
RDY vs IMVT Comparison
Compare RDY & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- IMVT
- Stock Information
- Founded
- RDY 1984
- IMVT N/A
- Country
- RDY India
- IMVT United States
- Employees
- RDY N/A
- IMVT N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RDY Health Care
- IMVT Health Care
- Exchange
- RDY Nasdaq
- IMVT Nasdaq
- Market Cap
- RDY 2.1B
- IMVT 2.5B
- IPO Year
- RDY N/A
- IMVT N/A
- Fundamental
- Price
- RDY $14.71
- IMVT $14.85
- Analyst Decision
- RDY Buy
- IMVT Buy
- Analyst Count
- RDY 1
- IMVT 10
- Target Price
- RDY $17.00
- IMVT $40.14
- AVG Volume (30 Days)
- RDY 1.6M
- IMVT 1.2M
- Earning Date
- RDY 05-09-2025
- IMVT 05-29-2025
- Dividend Yield
- RDY 0.65%
- IMVT N/A
- EPS Growth
- RDY 1.46
- IMVT N/A
- EPS
- RDY 0.79
- IMVT N/A
- Revenue
- RDY $3,809,801,863.00
- IMVT N/A
- Revenue This Year
- RDY $10.24
- IMVT $108.88
- Revenue Next Year
- RDY N/A
- IMVT N/A
- P/E Ratio
- RDY $18.43
- IMVT N/A
- Revenue Growth
- RDY 16.61
- IMVT N/A
- 52 Week Low
- RDY $12.26
- IMVT $12.72
- 52 Week High
- RDY $16.89
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- RDY 63.81
- IMVT 50.48
- Support Level
- RDY $14.24
- IMVT $13.79
- Resistance Level
- RDY $14.77
- IMVT $15.22
- Average True Range (ATR)
- RDY 0.20
- IMVT 0.69
- MACD
- RDY 0.04
- IMVT 0.13
- Stochastic Oscillator
- RDY 95.59
- IMVT 78.24
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).